The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,

Slides:



Advertisements
Similar presentations
Surveillance/ Screening Colonoscopy for Colorectal Cancer
Advertisements

STAGING MCR Staff Show Me Healthy Women March 27, 2008 Supported by a Cooperative Agreement between DHSS and the Centers for Disease Control and Prevention.
Polyps – Where do they come from and what do you do with them?!
Management of Malignant Polyps Santhat Nivatvongs, MD Colon and Rectal Surgery Mayo Clinic Rochester Minnesota U.S.A.
AJCC Staging Moments AJCC TNM Staging 7th Edition Rectal Case #3 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
AJCC TNM Staging 7th Edition Colon Case #1
The Adenoma/Carcinoma Sequence in the Colon
National Program of Cancer Registries Education and Training Series How to Collect High Quality Cancer Surveillance Data.
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
AJCC Staging Moments AJCC TNM Staging 7th Edition Glottic Larynx Case #1 Contributors: Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New York,
What is TNM? TNM is a system for classifying malignant tumours ! It is a cancer staging system, which describes the extent of a person's cancer ! Most.
Malignant colonic polyp: endoscopic treatment updates
Staging of Esophageal Cancer. A major change between the 2002 and the 2010 TNM staging system is the development of separate stage groupings according.
Joint Hospital Surgical Grand Round 19 June 2004.
Reporting and Management of Early stage Colorectal Cancer Frank Carey Dundee.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Treatment of Early Malignant Rectal Polyp
General Medicine Subspecialty Conference Colon Cancer Screening General Medicine Subspecialty Conference Colon Cancer Screening Selim Krim, MD Assistant.
AJCC Staging Moments AJCC TNM Staging 7th Edition Colon Case #2 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
COLORECTAL MALIGNANCIES Divina B. Esteban, M.D., FPSMO Rizal Medical Center.
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
TREATMENT OF LARGE AND GIANT COLORECTAL POLYPS IN THE REAL WORLD UEGW, PARIS, 2007 Association pour le Dépistage du Cancer colorectal dans le Haut-Rhin.
Colorectal carcinoma Dr.Mohammadzadeh.
Colorectal cancer Khayal AlKhayal MD,FRCSC Assistant professor of Surgery Consultant Colorectal surgeon 9/11/2015Shwartz.
Slides last updated: March 2015 CRC: STAGING. How colorectal cancer (CRC) is staged 1 Stage describes the extent of cancer, and is one of the most important.
COLON CANCER A MAJOR ISSUE IN ALASKA. A common malignancy 200,000 cases in the U. S. in ,000 cases in the U. S. in 2008 Greater than 50 new cases.
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
Bladder cancer is the second most common cancer of the genitourinary tract. The incidence is higher in whites than in African Americans. The average age.
A 58 years old man presents with melena. What would you ask him?
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
Datum/Vortragsthema Local resection of Rectum tumors Peter M. Markus Elisabeth Hospital Essen Germany.
Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates.
The “Hand” of Appendix Cancer Presented to American Association of Primary Care Endoscopy Brian W. Meeker, D.O. Vinton, Ia. 53 y/o male presents for “screening”
LCC REC-1 Φ π π π Φ Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) Rectal Cancer.
16/12/2012 Mr. Ravi-Kumar Stafford General Hospital1 ABC of CRC (Colo-Rectal Carcinoma) Mr Ravi-Kumar Consultant Surgeon Coloproctology, Laparoscopy &
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
MALIGNANT POLYPS DURING THE FIRST THREE SCREENING ROUNDS ( ) FOR COLON-RECTAL CANCER (CRC) IN A NORTH-EASTERN SANITARY DISTRICT (ULSS-1 VENETO).
TNM Staging: Colon and Rectum
Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry
Nicole Catlett, CTR KCR Abstractor’s Training April 21-23,
ajcc TNM Staging: chapter 1, and Summary stage
Collaborative Staging for Colon Site Specific Factors Tonya Brandenburg, MHA, CTR QA Manager Abstracting and Coding Kentucky Cancer Registry.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
Interventions for Clients with Colorectal Cancer.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society.
위암병리보고서의 기재사항 서울대학교 김 우 호.
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification R1 김진숙 / Prof. 장재영.
Cancer: Staging and Grading What is meant by the term “biopsy”? How do tumors behave differently from one another ? Examples of the stages of cancer and.
Measurement of SM invasion depth by ‘Committee of Management for sm Carcinoma Project’ of the Japanese Society for Cancer of the Colon and Rectum J Gastroenterol.
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Case. Kreem is 53 year old man who is quite healthy with no previous illness. He has noticed changes in his bowel habits for the last few months, with.
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,
Gastric Cancer Pathology. Malignant Neoplasms of the Stomach Primary Adenocarcinoma (94%) Lymphoma (4%) Malignant GIST (1%) Haematogenous spread Breast.
Multiple Primary and Histology Coding Rules Colon Cancer
Dr.Amit Gupta Associate Professor Dept. of Surgery
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Jasper Vleugels PhD-student AMC
Cancer Staging.
A cancer staging primer: Esophagus and esophagogastric junction
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Colon AJCC Case Answers
Focus on colon cancer Cancer Cell
Polyps of the Colon and Rectum
Changes in TNM 8 To be used from
Presentation transcript:

The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont, CO

Objectives Understand the definition of the malignant polyp, related pathology reports, and potential varying terminology Recognize the potential malignant polyp endoscopically, and plan accordingly for initial best management, including strategies for removal and tagging Manage the malignant polyp according to evidence-based guidelines, including proper referral and surveillance recommendations

Alternative Nomenclature Tis Intramucosal Adenocarcinoma Intramucosal Cancer Carcinoma In Situ Severe Dysplasia High-Grade Dysplasia (preferred)

Definition of Malignant Polyp A polyp with cancer invading through the muscularis mucosae, (pT1) into the submucosa Note: pTis is not considered a “malignant polyp” – no biological potential to metastasize ICD (Carcinoma In Situ of Colon)

Surveillance Recommendations for pTis Patients with 3-10 adenomas, or any adenoma >1cm, or any adenoma with villous features, or high-grade dysplasia should have their next follow-up colonoscopy in 3 years providing that piecemeal removal has not been done and the adenoma(s) are completely removed If the follow-up colonoscopy is normal or shows only one or two small tubular adenomas with low-grade dysplasia, the the interval for the subsequent examination should be 5 years

Follow-up pTis of Sessile Polyp Removed Piecemeal or ? Complete Resection Repeat colonoscopy within 3-6 months If residual tissue is identified, this should be removed with repeat colonoscopy in 3-6 mo. If a polyp cannot be completely removed within 1-3 examinations, surgery is recommended

Pathologic pTNM Classification Primary Tumor (T) TX: Cannot be assessed T0: No evidence of primary tumor Tis: Carcinoma in situ, intraepithelial or invasion of lamina propria/muscularis mucosae T1: Tumor invades submucosa T2: Tumor invades muscularis propria T3: Tumor invades through the muscularis propria into pericolorectal tissues T4a: Tumor penetrates the visceral peritoneum T4b: Tumor directly invades or is adherent to other organs or structures Regional Lymph Nodes (N) NX: Cannot be assessed N0: No regional lymph node metastasis N1a: Metastasis in 1 regional lymph node N1b: Metastasis in 2 to 3 regional lymph nodes N1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirectal tissues without regional lymph node metastasis N2a: Metastasis in 4 to 6 regional lymph nodes N2b: Metastasis in 7 or more regional lymph nodes Distant Metastasis (pM) MX: Distant metastasis cannot be assessed M0: No distant metastasis M1: Distant metastasis M1a: Metastasis to single organ or site (eg, liver, lung, ovary, nonregional lymph node) M1b: Metastasis to more than 1 organ/site or to the peritoneum

T1-Who may not need referral 1)Single specimen 2)Completely removed (clean margin) 3)Favorable histologic features-no angiolymphatic invasion, grade 1 or 2

Risk factors for polyps with high-grade dysplasia or cancer Villous histology (20-30% of polyps >1cm) Larger polyps (>2cm, 20% risk of cancer) Increased age of patient Increased number of polyps (24% risk of advanced pathology if h/o >5 adenomas at baseline colonoscopy) Use narrow band if available to anticipate path

pT1-Pedunculated vs. Sessile Sessile - Observation may be considered, with the understanding that there is significantly greater incidence of adverse outcomes Pedunculated polyps with cancer confined to the submucosa and without evidence of unfavorable histologic factors have a 0.3% risk of cancer recurrence or lymph-node metastasis after complete removal vs. 4.8% for similar sessile polyps

Malignant Polyp pT1 Fragmented Polyp => colectomy Margin Cannot be Assessed => colectomy Unfavorable Histologic Features => colectomy (grade 3 or 4, angiolymphatic invasion, positive margin of resection (presence of tumor within 1-2mm from the transected margin, or the presence of tumor cells within the diathermy of the transected margin))

Summary Tis – Completely resected => repeat in 3y, then 5y – Incomplete => repeat in 3-6 months T1 – Pedunculated, completely resected => 1y – Sessile, completely resected => 1y or surgery – Fragmented, ? margin, positive margin, unfavorable histology => surgery

Bibliography National Comprehensive Cancer Network Guidelines Version Colon Cancer Guidelines for Colonoscopy Surveillance after Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer (Gastroenterology 2012;143: ) ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer (Gastrointestinal Endoscopy 2005;61:1-7)